This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

AI-companion providers served with legal notices, Australian regulator says

( October 23, 2025, 00:20 GMT | Official Statement) -- MLex Summary: Legal notices have been issued to four artificial intelligence companion chatbot providers requiring them to explain the measures they are taking to protect children from online harms, the Australian online safety regulator said. In a statement on Thursday, the Australian eSafety Commissioner said that notices were given to Character.AI, Glimpse.AI, also known as Nomi, Chai Research Corp, and Chub.AI under Australia’s 2021 Online Safety Act. The statement added that the notices require these providers to report on the steps they are taking to keep Australian children safe online. The regulator said that the providers that fail to comply with the watchdog’s reporting notice could face enforcement action, including financial penalties of up to A$825,000 ($535,103) per day.The full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login